Bausch

Bausch + Lomb was valued at US$6.48 billion in its US market debut on Friday (May 6) as the eye-care company's shares opened nearly 3 per cent above an offer price that was well below the targeted range. The modest reception from investors…

Bausch Health: "We wanted to buy more today, but we ran out of time. This thing is being put on sale. There are shorts taking it all the way down. It is quite ridiculous. I wanted to be able to buy a huge slug of it today, so that's how I…

Check out the companies making headlines before the bell:Affirm Holdings (AFRM) – Affirm soared 22.4% in the premarket as the "buy now, pay later" company's revenue easily topped estimates. Active merchant numbers more than quintupled and…